The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)
Advanced Search

Session Details

Poster Presentation(A) Pharmaceutical Chemistry

Modalities, biomolecules, biologics/Targeting/Pharmacologically active compounds (incl. metabolites)/Structure-activity relationship

Sat. Mar 30, 2024 8:30 AM - 12:00 PM JST
Sat. Mar 30, 2024 11:30 PM - 3:00 AM UTC
[Poster 3] Exhibition Hall AB (1F)

[30P-am090S]Synthetic study on affilin for the application to a mirror-image protein scaffold

○Yukino Sato1, Naoya Iwamoto2, Shinya Oishi1,2 (1. Kyoto Pharm. Univ., 2. Grad. Sch. Pharm. Sci., Kyoto Univ.)

[30P-am091]Development of human light chain catalytic antibodies targeting the NAC region of α-synuclein

○Hiroaki Taguchi1, Naoya Hatsuyama1, Emi Hifumi2, Taizou Uda3 (1. Grad. Sch. Pharm. Sci. Suzuka Univ. Med. Sci., 2. Res. Manag., Ohita Univ., 3. Ins. Sys., Inf. Tech. and Nanotech.)

[30P-am092]Removal of Double-Stranded RNA from In Vitro Transcribed mRNA by Reversed-Phase High-Performance Liquid Chromatography using Macroporous Resins

○Yuki Higuchi1, Saoko Nozawa1, Taeko Nakajima1, Akinari Awatani1,2, Takashi Sekida2 (1. YMC CO., LTD., 2. VLP Therapeutics Japan)

[30P-am093S]Development of a fusogenic liposome for the cytosolic protein delivery

○Yurie Yamaguchi1, Sota Yamada1,2, Kenjiro Hanaoka1,2 (1. Pharm. Sci., Keio Univ., 2. Grad. Sch Pharm. Sci., Keio Univ.)

[30P-am094]Development of one-step establishment method for adeno-associated virus (AAV) producer cell and high production technology

○Yusuke Mori1, Taichi Muraguchi1, Katsuko Sato1, Takeshi Yamamoto1 (1. FUJIFILM Corp.)

[30P-am095]Development of homogeneous ADC production method using one-step glycan remodeling

○kanamori satoshi1, hyongi chon2, kazuhiro hibino1, takashi nagahara2, tomohiko suzuki2, keiichiro ohara1, hideki narumi1 (1. MicroBiopharm Japan Co.,Ltd, 2. Toray Industries, Inc.)

[30P-am096S]Inhibition of Influenza A virus replication by Lipid-siRNA conjugates

○Rina Tanso1, Takanori Kubo, Kinjiro Morimoto, Yuta Hatori, Toshio Seyama (1. Yasuda Women's Univ.)

[30P-am097S]Designing an artificial biomembrane model containing lipid peroxide by irradiating atmospheric pressure low-temperature plasma

○Airi Watanabe1, Yukiyo Nomura1, Daigo Chigira1, Yukiko Moriiwa1, Kazuhiro Morioka1, Akio Yanagida1, Akitoshi Okino2, Atsushi shouji1 (1. Tokyo.Univ.Pharm.Life Sci., 2. Tokyo.Univ.Eng.)

[30P-am098]Survey and Consideration for Evaluation of Plasma/Serum Protein Binding of Globally-Approved Oligonucleotide Therapeutics

○Kei Fukuhara1,2, Mika Miyoshi1,3, Naomi Tamura1,4, Yutaka Niwayama1,5, Yasufumi Fukano1,6, Shunji Imai1,7 (1. Japan Pharmaceutical Manufacturers Association, 2. Pfizer R&D Japan, 3. Sanwa Kagaku Kenkyusho, 4. Shionogi, 5. Kyorin Pharmaceutical, 6. Nippon Boehringer Ingelheim, 7. Nippon Shinyaku)

[30P-am099]Novel estrogen receptor modulators activated by reactive oxygen species (ROS) in cancer cells

○Kiminori Ohta1, Yuito Imai1, Hokuto Ehara1, Asako Kaise2 (1. Sch. Pharm., Showa Univ., 2. Fac. Pharm. Sci., Tohoku Med. Pharm. Univ.)

[30P-am100]Japan's contribution to development of Ca antagonists and new aspect from redox regulation

○Masato Kamibayashi1, Ikuo Nakanishi2, Hisashi Matsuda1, Yoshiaki Manse1, Toshio Morikawa1,3 (1. Pharm. Res. Technol. Inst., Kindai Univ., 2. Inst. Quant. Life Sci., Natl. Inst. Quant. Sci. Technol., 3. Antiaging Cent., Kindai Univ.)

[30P-am101S]Discovery of Acyclic Retinoid Derivatives with Enhanced Growth Inhibitory Activity against Hepatocellular Carcinoma

○Naoki Hirokawa1, Noriyoshi Tanaka2, Kazuma Mizuno1, Kota Tonegawa1, Ichiro Yajima1, Yoshitomo Suhara1 (1. Grad. Shibaura institute of technology, 2. Shibaura institute of technology)

[30P-am102S]Exploring novel vitamin K derivatives with GGCX inhibitory activity

○Koki Usami1, Xuejie Chen2, Jian-Ke Tie2, Yoshitomo Suhara1 (1. Grad. shibaura institute of technology, 2. University of North Carolina)

[30P-am103S]Search for a potent inhibitor of melanogenesis from secondary metabolites of the soil fungus and their mechanism of action

○Hiromi Torii1, Tadahiro Etoh1, Karin Hashimoto1, Eri Tsumoto1, Fuma Hiki1, Kurumi Ayabe1, Yong Pil Kim1,2 (1. Iryo Sosei University Faculty of Pharmacy, 2. Iryo Sosei University graduate School of Life Science and Technology)

[30P-am104]Synthesis and effects of N-alkyl thiophene carboxamides with ethylene glycol units on human lung cancer cells A549: Investigating ethylene glycol units, tails, and linker moieties

○Naoto Kojima1, Kaito Ohta2, Hiromi Ii2, Chiami Moyama2, Maho Masuda2, Hiroki Iwasaki2, Hisanori Nambu2, Susumu Nakata2 (1. Fac. Pharm. Sci., Nagasaki Int. Univ., 2. Kyoto Pharm. Univ.)

[30P-am105]Development of antimicrobial peptide foldamers containing cationic disubstituted amino acids.

○Takashi Misawa1, Takahito Ito1,2, Megumi Kurashima1, Yosuke Demizu1,2 (1. National Institute of health sciences, 2. Grad. Sch. Med. Life Sci., Yokohama city Univ.)

[30P-am106S]Development of Novel AR Antagonists Based on Nitrogen-containing Heterocyclic Skeleton

○Sarara Izumi1, Ryosuke Ishida2, Hiroyuki Kagechika2, Aya Tanatani1 (1. Grad. Sch. Adv. Sci., Ochanomizu Univ., 2. Inst. Biomater. Bioeng., Tokyo Med. Den. Univ)

[30P-am107S]Synthesis and evaluation of Trichothecinol A and its analogues as STAT3 inhibitors

Mitsuaki Yamashita1, ○Kiyoshige Nakamoto1, Akira Iida1 (1. Grad.Sch.Agri.,Kindai Univ)

[30P-am108]Exploratory research on new derivatives effective against multidrug-resistant Mycobacterium tuberculosis

Mayu Kagawa1, Momoka Nagashima1, Mami Ohtani1, Takuya Sunouchi1, Hiroyuki Fuchino2, Teruo Kirikae3, Fumiko Kirikae3, ○Ken-ichi Kurihara1 (1. Faculty of Pharm. Sci., Teikyo Heisei Univ., 2. Research Center for Medicinal Plant Resources, NIBIOHN, 3. Juntendo Advanced Reseach Institute for Health Science)

[30P-am109S]Development of Efficient Synthesis of Polycyclic Quinones Using the Diels-Alder Reaction and Evaluation of Their Antimicrobial Activity

Mitsuaki Yamashita1, ○Masaaki Hasegawa1, Youichi Fukuda1, Akira Iida1 (1. Grad.Sch.Agri.Kindai Univ)

[30P-am110S]Development of novel lithocholic acid derivatives bearing carbamate moiety in the side chain as vitamin D receptor agonists

○Kana Okamura1, Marika Minami1, Naoya Hirata2, Yasunari Kanda2, Makoto Makishima3, Michiyasu Ishizawa3, Hiroyuki Masuno4, Hiroyuki Kagechika4, Aya Tanatani1 (1. Grad. Sch. Humanities and Sci., Ochanomizu Univ., 2. National Institute of Health Sciences, 3. Nihon University School of Medicine, 4. Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental Univ.)

[30P-am111]The Specific Effects of Phthalimide on Molecular Recognition by Serine Proteases

○Hiroshi Aoyama1, Sarasa Urushiyama1, Takayuki Nagae1, Mitsuhiro Takeda1, Masaki Mishima1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci.)

[30P-am112S]Synthesis of cladosporin-febrifugine complex targeting aminoacyl-tRNA synthetase

○Momo Torigoe1, Mizuki Sato2, Satomi Ishibashi1, Takehiro Nishimura1, Haruhisa Kikuchi1,2 (1. Fac. Pharm., Keio Univ., 2. Grad. Sch. Pharm. Sci., Tohoku Univ.)

[30P-am113S]Structure-Activity Relationship of Matrine type Alkaloids Part; 36
Synthesis and Evaluation of Antinociception of 4-(Chlorophenyl)piperidine Derivatives

○Yuki Matsumoto1, Yamato Takahashi1, Takumi Takahashi1, Yuriko Matoba1, Yuuki Takahashi1, Melanny Ika Sulistyowaty1,2, Taichi Sugimoto1, Ryota Moriwaki1, Hiroaki Teramoto1, Takayasu Yamauchi1 (1. Hoshi Univ., 2. Faculty of Pharm., Airlangga Univ.)

[30P-am114]Studies on the Synthesis and Structure–Activity Relationship of Carbon-Substituted Analogues of Marrubiin, an Inhibitor of Aorta Contraction

Mina Nakamura1, ○Kazutada Ikeuchi2, Hiroaki Kito3, Susumu Ohya3, Seichi Nakamura2 (1. Fac. Sch. Pharm. Sci., Nagoya City Univ., 2. Grad. Pharm. Sci., Nagoya City Univ., 3. Grad. Sch. Med. Sci., Nagoya City Univ.)

[30P-am115S]Development of aromatic cis-amide derivatives as novel Androgen Receptor antagonists

○Ayano Ikeda1, Ryosuke Ishida2, Masatoshi Kawahata3, Kosuke Katagiri4, Hiroyuki Kagechika2, Aya Tanatani1 (1. Grad. Sch. Adv. Sci., Ochanomizu Univ., 2. Inst. Biomater. Bioeng., Tokyo Med. Den. Univ., 3. Fac. Pharm. Sci., Showa Phama. Univ., 4. Fac. Sci. Eng., Konan Univ.)

[30P-am116S]Structure-activity relationship studies of structurally simplified analogues of Ansellone J

○Kanae Nakahara1, Naoki Kishimoto2, Mizushi Yanagihara3, Towa Abe2, Satoshi Miura4, Shunsuke Sasaki2, Tae Yasutake4, Shogo Misumi2, Makoto Sako3, Mitsuhiro Arisawa3, Kenichi Murai3 (1. School of Pharmaceutical Sciences, Osaka University, 2. Graduate School of Pharmaceutical Sciences, Kumamoto University, 3. Graduate School of Pharmaceutical Sciences, Osaka University, 4. School of Pharmaceutical Sciences, Kumamoto University)

[30P-am117S]Development of novel FXR agonists based on the conformational properties of aromatic amide and related functional groups

○Ayaka Nakamichi1, Michiyasu Ishizawa2, Makoto Makishima2, Yue Ma3, Hiroyuki Kagechika3, Aya Tanatani1 (1. Grad. Sch. Adv. Sci., Ochanomizu Univ., 2. Sch. Med., Nihon Univ., 3. Inst. Biomater. Bioeng., Tokyo Med. Den. Univ.)

[30P-am118S]Structure-Activity Relationship Study of Tetrahydrocarbazole Derivatives Inhibiting HCV Particle Formation

○Hijiri Kishikawa1, Junko Fujimoto2, Kohei Sato1,2, Nobuyuki Mase1,2, Tetsuro Suzuki3, Tetsuo Narumi1,2 (1. Department of Engineering, Graduated School of Integrated. Science. Technology, Shizuoka University, 2. Faculty of Engineering, 3. Hamamatsu University School of Medicine)

[30P-am119]Transnitrosation and structure-activity relationship of cyclic N-nitroso compounds

○keisuke tsuchiya1, Masataka Mochizuki1, Keiko Inami1 (1. Fac. Pharm. Sci., Sanyo-Onoda City Univ.)

[30P-am120]Studies on Structure-Activity Relationship of ferulic acid derivative between antioxidant effect and cytoprotective effect

○Koichi Shikama1, Jun Takayama1, Meiyan Xuan1, Hirokazu Matsuzaki1, Bo Yuan1, Mari Okazaki1, Takeshi Sakamoto1 (1. Fac. Pharm. Sci., Josai Univ.)
Back to Category List